Keywords: Dengue vaccines, Phase III, Sanofi Pasteur, Sanofi-Aventis

Sanofi Pasteur's Dengue vaccine first to enter Ph III clinical trial

Article | 05 November 2010

Print This

French drug major Sanofi-Aventis’ (Euronext: SAN) vaccine unit, Sanofi-Pasteur, says that its Dengue vaccine is in final stage of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in